Skip to main content
Premium Trial:

Request an Annual Quote

OncoPlexDx Achieves CAP Accreditation for Clinical Lab

NEW YORK (GenomeWeb News) – OncoPlex Diagnostics said today that it has received certification of accreditation from the College of American Pathologists for its clinical laboratory facility.

The company's lab offers mass spec-based quantitation of oncoproteins in tissue, providing clinicians with protein expression data to guide patient treatment decisions.

CAP accreditation is an internationally recognized certification with standards that typically exceed standard regulatory requirements. OncoPlex is now both CAP-accredited and CLIA-certified for clinical processing of formalin-fixed, paraffin-embedded cancer tissue using selected-reaction monitoring mass spectrometry.

"Clinicians ordering our assays can have confidence that the results received are of the highest quality possible," OncoPlex CEO Jon Burrows said in a statement.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.